Two Interactive Midday Symposia
conducted at the
44th ASHP Midyear
Clinical Meeting and Exhibition
Emerging Therapies in the Treatment
of Heparin-Induced Thrombocytopenia
MONDAY, December 7, 2009 • 11:30 am – 1:30 pm
Palazzo Ballroom D, Level 5 • Venetian Hotels & Sands Expo Center
Las Vegas, Nevada
Download Program Handout [PDF]
Learning Objectives
After attending this application-based activity, attendees should be able to
- Define the criteria for diagnosis of heparin-induced thrombocytopenia (HIT).
- Summarize the current guidelines for the monitoring and treatment of HIT.
- Describe the most common challenges associated with currently available treatments for HIT.
- Name at least two emerging therapeutic options for the treatment of HIT.
- Identify three opportunities for pharmacist intervention to improve the care of patients with HIT.